Cascadian Therapeutics Inc (CASC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CASC | EBS | GHRS | ||
| Company | Cascadian Therapeutics Inc | Emergent Biosolutions | Gh Research Plc | ||
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | ||
| Open | 9.98 | 9.40 | 9.57 | ||
| High | 9.98 | 9.67 | 9.94 | ||
| Low | 9.98 | 9.37 | 9.05 | ||
| Last | 9.98 | 9.48 | 9.27 | ||
| Change | -0.04 | +0.08 | -0.35 | ||
| % Change | -0.40% | +0.85% | -3.64% | ||
| Volume | 2,000 | 799,300 | 61,800 | ||
| 20-Day Average Volume | 587,320 | 1,646,280 | 74,615 | ||
| Previous Close | 10.02 | 9.40 | 9.62 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 9.99 | 9.55 | 8.86 | ||
| 20-Day Raw Stochastic | 28.57% | 35.26% | 46.91% | ||
| 20-Day Relative Strength | 86.57% | 51.41% | 54.77% | ||
| Weighted Alpha | +65.20 | +62.24 | +9.21 | ||
| Today's Opinion | N/A | 56% Buy | 40% Sell | ||
| Previous Opinion | N/A | 56% Buy | 24% Sell | ||
| Last Month's Opinion | N/A | 88% Buy | 56% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.20% since 03/02/18 | +22.80% since 11/15/24 | +1.98% since 11/15/24 | ||
| Low | 9.98 on 03/09/18 | 7.81 on 11/18/24 | 9.05 on 11/22/24 | ||
| High | 10.03 on 03/08/18 | 9.78 on 11/21/24 | 11.09 on 11/20/24 | ||
| 1-Month | |||||
| %Chg | -0.10% since 02/09/18 | +2.71% since 10/22/24 | +11.69% since 10/22/24 | ||
| Low | 9.96 on 02/22/18 | 7.71 on 11/15/24 | 7.02 on 10/23/24 | ||
| High | 10.03 on 03/08/18 | 12.73 on 11/07/24 | 11.09 on 11/20/24 | ||
| 3-Month | |||||
| %Chg | +157.22% since 12/08/17 | -0.21% since 08/22/24 | -16.56% since 08/22/24 | ||
| Low | 3.52 on 01/08/18 | 5.69 on 09/25/24 | 6.00 on 10/07/24 | ||
| High | 10.21 on 01/31/18 | 12.73 on 11/07/24 | 12.11 on 08/28/24 | ||
| 6-Month | |||||
| %Chg | +177.99% since 09/08/17 | +88.84% since 05/22/24 | -27.01% since 05/22/24 | ||
| Low | 3.42 on 09/12/17 | 4.51 on 05/29/24 | 6.00 on 10/07/24 | ||
| High | 10.21 on 01/31/18 | 15.10 on 07/30/24 | 14.99 on 06/05/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 507,212 | 509,330 | 500,509 | ||
| Shares Outstanding, K | 50,620 | 54,184 | 52,028 | ||
| Annual Sales | 0 | 1,049,300,000 | 0 | ||
| Annual Net Income | -56,930,000 | -760,500,000 | -35,590,000 | ||
| Last Quarter Sales | N/A | 293,800,000 | 0 | ||
| Last Quarter Net Income | N/A | 114,800,000 | -12,110,000 | ||
| 60-Month Beta | 3.80 | 1.57 | 0.74 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.28 on 11/08/17 | 1.37 on 11/06/24 | -0.23 on 11/14/24 | ||
| Latest Earnings Date | 03/08/18 | 11/06/24 | 11/14/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | 11/13/12 | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||